Association of VEGFA Polymorphisms with the Risk of Oesophageal Cancer in Punjab, India: A Case-control Study

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2024 Oct 9

PMID 39382410

Authors

Kamlesh Guleria

Vasudha Sambyal

Sukhpreet Kaur Walia

Meena Sudan

Manjit Singh Uppal

Affiliations

Soon will be listed here.

Abstract

Background & objectives Vascular endothelial growth factor (VEGF) is one of the most important angiogenic factors which stimulates tumour progression induction of endothelial cell migration and division, inhibition of the apoptosis of endothelial cells, induction of serine protease activity and enhancement of vascular permeability. This study aimed to investigate the correlation of VEGF+405G/C,-7C/T and+936C/T polymorphisms with oesophageal cancer risk. Methods DNA samples of 464 subjects (231 sporadic oesophageal cancer affected individuals and 233 controls) were genotyped forVEGF+936C/T,+405G/C and-7C/T polymorphisms. VEGF+936C/T and +405G/C polymorphisms were genotyped by PCR-RFLP method whereas VEGF-7C/T polymorphism was genotyped using Amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). Results CT genotype of VEGF-7C/T polymorphism was significantly associated with reduced risk of oesophageal cancer. VEGF-7C/T polymorphism was significantly associated with reduced risk of oesophageal cancer underdominant, co-dominant, over dominant and log-additive genetic models in total patients and in the female group. C+936G+405T-7 haplotype was significantly associated with decreased risk (P=0.01)of oesophageal cancer in total patients and also in the male group (P=0.02). Interpretation & conclusions In future, replication of the findings of the present study in a larger sample from different ethnic groups, along with functional analysis, may be insightful for the role of VEGFA polymorphisms in the pathogenesis of oesophageal cancer. Identification of the correlation of VEGF variants with specific therapy in oesophageal cancer may help in better selection of patients and monitoring treatment response in VEGF-therapy.

References

Fatima L, Campello R, Santos R, Freitas H, Frank A, Machado U . Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue. Sci Rep. 2017; 7(1):16716. PMC: 5711936. DOI: 10.1038/s41598-017-16686-7. View

Zhai R, Liu G, Asomaning K, Su L, Kulke M, Heist R . Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis. 2008; 29(12):2330-4. PMC: 2639251. DOI: 10.1093/carcin/bgn210. View

Schuster S, Hsieh A . The Untranslated Regions of mRNAs in Cancer. Trends Cancer. 2019; 5(4):245-262. PMC: 6465068. DOI: 10.1016/j.trecan.2019.02.011. View

Jain L, Vargo C, Danesi R, Sissung T, Price D, Venzon D . The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther. 2009; 8(9):2496-508. PMC: 2751847. DOI: 10.1158/1535-7163.MCT-09-0302. View

Xu B, Li J, Tong N, Tao J, Li P, Song N . VEGFA +936C>T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet. 2010; 198(1):7-14. DOI: 10.1016/j.cancergencyto.2009.11.007. View

Tamura T, Kuwahara A, Yamamori M, Nishiguchi K, Nakamura T, Okuno T . VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Int J Med Sci. 2012; 9(10):833-7. PMC: 3498747. DOI: 10.7150/ijms.4914. View

Yamamori M, Sakaeda T, Nakamura T, Okamura N, Tamura T, Aoyama N . Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun. 2004; 325(1):144-50. DOI: 10.1016/j.bbrc.2004.10.005. View

Chae Y, Kim J, Sohn S, Cho Y, Ahn B, Moon J . Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci. 2008; 23(3):421-7. PMC: 2526538. DOI: 10.3346/jkms.2008.23.3.421. View

Lorenzen S, Panzram B, Keller G, Lordick F, Herrmann K, Becker K . Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction. Mol Imaging Biol. 2010; 13(1):178-86. DOI: 10.1007/s11307-010-0330-0. View

10.

Qasim I, Bhat I, Masoodi K, Shah Z . Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene and risk of esophageal cancer in the Kashmiri population. Asian Pac J Cancer Prev. 2015; 16(1):97-101. DOI: 10.7314/apjcp.2015.16.1.97. View

11.

Hall M, Krishnanandan V, Cheung M, Coburn N, Haas B, Chan K . An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical Trials. J Natl Cancer Inst. 2022; 114(8):1186-1191. PMC: 9360459. DOI: 10.1093/jnci/djac092. View

12.

Bradbury P, Zhai R, Ma C, Xu W, Hopkins J, Kulke M . Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. Clin Cancer Res. 2009; 15(14):4680-5. PMC: 2742698. DOI: 10.1158/1078-0432.CCR-09-0192. View

13.

Sibertin-Blanc C, Mancini J, Fabre A, Lagarde A, Del Grande J, Levy N . Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer. Dig Liver Dis. 2015; 47(4):331-7. DOI: 10.1016/j.dld.2014.12.013. View

14.

Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N . Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog. 2008; 48(6):563-9. DOI: 10.1002/mc.20495. View

15.

Yang P, Hsieh M, Huang Y, Hsieh C, Chiang T, Lee J . Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma. PLoS One. 2014; 9(6):e100326. PMC: 4063891. DOI: 10.1371/journal.pone.0100326. View

16.

Gu H, Qiu W, Shi Y, Chen S, Yin J . Variant alleles of VEGF and risk of esophageal cancer and lymph node metastasis. Biomarkers. 2014; 19(3):252-8. DOI: 10.3109/1354750X.2014.902997. View

17.

Guan X, Zhao H, Niu J, Tan D, Ajani J, Wei Q . Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res. 2009; 28:94. PMC: 2717936. DOI: 10.1186/1756-9966-28-94. View

18.

Kim J, Sohn S, Chae Y, Cho Y, Bae H, Yan G . Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol. 2007; 18(6):1030-6. DOI: 10.1093/annonc/mdm085. View

19.

Marquez-Garban D, Mah V, Alavi M, Maresh E, Chen H, Bagryanova L . Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids. 2011; 76(9):910-20. PMC: 3129425. DOI: 10.1016/j.steroids.2011.04.015. View

20.

Rudnicki M, Abdifarkosh G, Rezvan O, Nwadozi E, Roudier E, Haas T . Female Mice Have Higher Angiogenesis in Perigonadal Adipose Tissue Than Males in Response to High-Fat Diet. Front Physiol. 2018; 9:1452. PMC: 6206240. DOI: 10.3389/fphys.2018.01452. View